Induction chemotherapy followed by concomitant chemoradiotherapy for advanced head and neck cancer: Impact on the natural history of the disease

Keyphrases

• 5-fluorouracil (5-FU) 66%
• Cancer Patients 33%
• Cisplatin 33%
• Clinical Complete Response 33%
• Concurrent Chemoradiotherapy 100%
• Concurrent Radiation 33%
• Confidence Interval 33%
• Disease Progression 33%
• Distant Control 33%
• Failure Pattern 33%
• Fluorouracil 33%
• Follow-up Interval 33%
• Head-and-neck Cancer 100%
• High Toxicity 33%
• Highly Active 33%
• Hydroxyurea 33%
• Impact of Cancer 100%
• Induction Chemotherapy 100%
• Interferon alpha-2b 33%
• Leucovorin 33%
• Life-threatening 33%
• Limited Surgery 33%
• Local Control 33%
• Local Therapy 33%
• Long-term Survival 33%
• Major Risk 33%
• Medical Illness 33%
• Mucositis 66%
• Myelosuppression 33%
• Natural History 100%
• Organ Function 33%
• Overall Survival Rate 66%
• Primary Tumor 33%
• Progression-free 33%
• Second Malignancy 66%
• Stage IV Disease 33%
• Surgical Resection 33%
• Survival Rate 33%
• Total Radiation 33%
• Treatment Duration 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Alpha2b Interferon 33%
• Bone Marrow Suppression 33%
• Chemoradiation Therapy 100%
• Chemotherapy 100%
• Cisplatin 33%
• Disease 100%
• Disease Exacerbation 33%
• Fluorouracil 33%
• Folinic Acid 33%
• Head and Neck Cancer 100%
• Hydroxycarbamide 33%
• Long Term Survival 33%
• Mucosa Inflammation 66%
• Overall Survival 66%
• Primary Tumor 33%
• Progression Free Survival 33%
• Recurrent Disease 33%
• Second Cancer 66%
• Survival Rate 100%